表紙：北米のAI支援医療画像市場
市場調査レポート
商品コード
1804836

北米のAI支援医療画像市場

North America AI-assisted Medical Imaging Market

出版日
ページ情報
英文 54 Pages
納期
即納可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.69円
北米のAI支援医療画像市場
出版日: 2025年09月04日
発行: Marketstrat, Inc.
ページ情報: 英文 54 Pages
納期: 即納可能
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

調査範囲

  • 国米国、カナダ
  • モダリティCT、MRI、X線/DR、超音波、PET/核医学
  • 臨床分野腫瘍学、神経学/脳卒中、心臓病学、呼吸器/肺、MSK/整形、一般
  • 用途トリアージ→検出→再構成→統合
  • 収益の流れハードウェア、ソフトウェア、サービス、クラウド/利用料金制
  • 最終用途病院/IDN、画像診断センター、クリニック、遠隔放射線医療、その他.（セクション2、目的と範囲）

調査手法

二重レンズアプローチ：トップダウンはNA合計と国別分割への調整、ボトムアップは工場出荷と後付けの混合、ASPバンド、NA特有のエビデンスウェイト（FDA/Health Canada cadence、償還シグナル、企業購買、RWE）を用いたモダリティ別装着率促進要因。

レポート概要

  • 軌跡：北米は2032年までに132億ドルに拡大（CAGR30％）（エグゼクティブサマリー10ページ、表1 14ページ）。
  • 装着率のヘッドルーム：OEMのAIは、超音波とPETの両方で、新規CTの20％、新規MRサンプルランウェイの15％に搭載されます。（添付文書料金の考察と図3、pp.18-19.）

数字を動かしているもの

  • 診療報酬の引き下げ：CMSのNTAP更新（脳卒中AI）と、CT-FFR、エコー歪み、乳房AIのための新しいCPTスタックのおかげで、米国が引き続き優勢であり、対カナダで約9対1です。
  • 企業の購買力：米国の大手IDNは複数年の"AI-store"ライセンスをロックしており、基本的なスキャンの伸びを上回るスピードで支出を拡大しています。
  • 規制の明確化：FDAのPredetermined Change-Control Plan草案は、再申請なしでアルゴリズムのアップグレードを可能にし、更新サイクルを短縮し、ARRを向上させます。
  • カナダのキャッチアップ：一人払いの州は慎重な動きを見せるが、全国的な肺がん検診のパイロットとCADTH別結核AIのHTAが採用を後押し。CAGRは29%と低いが、それでも市場規模は3年ごとに倍増します。
  • 国境を越えたベンダー：米国のクラウドAIプロバイダーは、プライバシーのコンプライアンス（PIPEDA/HIPAA）が証明されれば、カナダの入札を獲得する傾向が強まり、その差はさらに縮まります。

レポートのメリット

  • どこで勝負するか/どう勝つかNAGTM成長・成熟度マトリックス、競合データセット、規制速度、M&Aウォッチリスト。（図と表、15-18ページ）。
  • 各国のプレイブック：米国とカナダのGTMレーダー、チャネル/価格設定マトリックス、顧客層の潜在的可能性、12ヶ月のアクションキューを含むタイムライン。（米国31～38頁、カナダ52～54頁）。
  • 予測の深さ：2032年までの国別、モダリティ別、臨床領域別、用途別、収益源別、最終用途別の内訳。（24-30、43-51ページにわたる表）。

目次

セクション1-エグゼクティブサマリー

セクション2-調査手法

セクション3-北米市場

  • 市場サマリー
    • 市場規模と促進要因
    • 最新動向
    • 戦略展望
    • 競合環境
    • 新たな重点分野
  • 北米市場の推定と予測（2023年～2032年）
  • Markintel GTM成長・成熟度マトリックス-北米
  • 規制の速度-北米
  • モダリティ別OEM AIアタッチ率

セクション4-米国市場

  • 市場サマリー-米国
  • 市場概要-米国
    • 人口統計と疫学
    • マクロ経済と医療費支出
    • イメージングボリュームとインストールベース
    • 規制と償還のスナップショット
    • ヘルスケア提供と実践パターン
    • AI市場力学（イメージング）
    • 競合情勢
    • ベンダーにとっての教訓
  • 米国市場、臨床領域別
  • 米国市場、画像診断法別
  • 米国市場、収益源別
  • 米国市場、臨床用途別
  • 米国市場、最終用途組織別
  • 米国市場、AI技術別
  • Markintel成長成熟度マトリックス-米国およびカナダ
  • Markintelソリューション導入および成長マトリックス-米国およびカナダ
  • Markintelエコシステムコラボレーションマトリックス-米国およびカナダ
  • GTM概要-米国

セクション5-カナダ市場

  • 市場サマリー：カナダ
  • 市場概要-カナダ
  • 臨床分野別カナダ市場
  • カナダ市場、臨床領域別
  • カナダ市場、画像診断法別
  • カナダ市場、収益源別
  • カナダ市場、臨床用途別
  • カナダ市場、最終用途組織別
  • カナダ市場、AI技術別
  • GTM概要- カナダ
図表

List of Figures

  • Figure 1: Markintel GTM Growth and Maturity Matrix - North America
  • Figure 2: Regulatory Velocity - North America
  • Figure 3: OEM AI Attach-Rate by Modality - North America
  • Figure 4: Factory vs Retrofit - North America
  • Figure 5: Markintel Growth Maturity Matrix - US & Canada
  • Figure 6: Markintel Solution Adoption & Growth Matrix - US & Canada
  • Figure 7: Markintel Ecosystem Collaboration Matrix - US & Canada
  • Figure 8: GTM Readiness Radar - US
  • Figure 9: Customer Tier Potential - US
  • Figure 10: GTM Timeline (2025-2028) - US
  • Figure 11: Regulatory x Funding Heatmap - US (2024)
  • Figure 12: Dual-Layer Adjacency-Opportunity Radar - US (Post-2026)
  • Figure 13: Whitespace Partner-Fit Matrix - US (2024-26)
  • Figure 14: GTM Readiness Radar - Canada
  • Figure 15: Market Potential by Customer Tier - Canada (2032)

List of Tables

  • Figure 1: Markintel GTM Growth and Maturity Matrix - North America
  • Figure 2: Regulatory Velocity - North America
  • Figure 3: OEM AI Attach-Rate by Modality - North America
  • Figure 4: Factory vs Retrofit - North America
  • Figure 5: Markintel Growth Maturity Matrix - US & Canada
  • Figure 6: Markintel Solution Adoption & Growth Matrix - US & Canada
  • Figure 7: Markintel Ecosystem Collaboration Matrix - US & Canada
  • Figure 8: GTM Readiness Radar - US
  • Figure 9: Customer Tier Potential - US
  • Figure 10: GTM Timeline (2025-2028) - US
  • Figure 11: Regulatory x Funding Heatmap - US (2024)
  • Figure 12: Dual-Layer Adjacency-Opportunity Radar - US (Post-2026)
  • Figure 13: Whitespace Partner-Fit Matrix - US (2024-26)
  • Figure 14: GTM Readiness Radar - Canada
  • Figure 15: Market Potential by Customer Tier - Canada (2032)
目次
Product Code: MINTP-M01120

Report Scope

  • Countries: United States, Canada
  • Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
  • Clinical Areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General
  • Applications: Triage -> detection -> reconstruction -> integration
  • Revenue Streams: Hardware, Software, Services, Cloud/Pay per Use
  • End use: Hospitals/IDNs, Imaging Centers, Clinics, Teleradiology, Other. (Section 2, Objective & Scope.)

Methodology

Dual lens approach: top down reconciliation to NA totals and country splits; bottom up attach rate engine by modality with factory vs retrofit mixes, ASP bands, and NA specific evidence weights (FDA/Health Canada cadence, reimbursement signals, enterprise buying, and RWE).

Report Snapshot

  • Trajectory: North America expands to ~US$13.2B by 2032 (~30% CAGR) . (Executive Summary, p.10; Table 1, p.14.)
  • Attach rate headroom: OEM AI ships on ~20% of new CT and ~15% of new MR-ample runway across ultrasound and PET. (Attach rate discussion & Figure 3, pp.18-19.)

What's Driving the Numbers

  • Reimbursement pull: The U.S. continues to dominate-about 9-to-1 versus Canada-thanks to CMS NTAP renewals (stroke AI) and the emerging CPT stack for CT-FFR, echo strain and breast-AI.
  • Enterprise buying power: Large U.S. IDNs lock multi-year "AI-store" licenses, scaling spend faster than underlying scan growth.
  • Regulatory clarity: FDA's Predetermined Change-Control Plan draft allows algorithm upgrades without re-filing, shortening refresh cycles and feeding ARR.
  • Canada's catch-up: Single-payer provinces move more cautiously, but national lung-cancer screening pilots and CADTH's positive HTA for TB AI push adoption. The lower 29 % CAGR still doubles market size every three years.
  • Cross-border vendors: U.S. cloud-AI providers increasingly win Canadian tenders once privacy compliance (PIPEDA/HIPAA) is proven, further narrowing the gap.

Report Benefits

  • Where to play / how to win: NA GTM Growth & Maturity Matrix, competitive dataset, regulatory velocity, and M&A watchlist. (Figures & tables, pp.15-18.)
  • Country playbooks: U.S. & Canada GTM radars, channel/pricing matrices, customer tier potential, and timelines with 12 month action cues. (U.S. pp.31-38; Canada pp.52-54.)
  • Forecast depth: Breakouts by country, modality, clinical area, application, revenue stream, and end use through 2032. (Tables across pp.24-30, 43-51.)

TABLE OF CONTENTS

SECTION 1 - EXECUTIVE SUMMARY

  • 25 second Read
  • Size & Trajectory
  • Modality & Attach rate Dynamics
  • Buyer & Route to Market
  • Competitive Temperature
  • What to do in the Next 12 Months

SECTION 2 - RESEARCH METHODOLOGY

  • Objective & Scope
  • Dual lens Architecture
  • North America-specific Evidence Stack & Weights
  • Calibration Choices (NA)

SECTION 3 - NORTH AMERICAN MARKET

  • Market Summary
    • Market Size & Drivers
    • Latest Trends
    • Strategic Outlook
    • Competitive Environment
    • New Focus Areas
  • North American Market Estimates & Forecasts (2023-2032)
    • AI Imaging Market by Country - North America
    • What's Driving the Numbers
    • Implications
  • Markintel GTM Growth and Maturity Matrix - North America
    • Competitive Dataset - North America
    • Competitive Context - North America AI-Imaging 2024
    • Strategic Takeaways
    • Growth & Maturity Highlights - North America
    • M&A Watchlist - North America Rising Stars
  • Regulatory Velocity - North America
  • OEM AI Attach-Rate by Modality
    • Attach Rate Trends - North America
    • Factory vs Retrofit - North America

SECTION 4 - UNITED STATES MARKET

  • Market Summary - United States
    • Key Market Dynamics
    • Strategic Takeaways
    • Top 3 Recommendations
  • Market Overview - United States
    • Demographics & Epidemiology
    • Macro economics & Health Spending
    • Imaging Volume & Installed Base
    • Regulatory & Reimbursement Snapshot
    • Healthcare Delivery & Practice Patterns
    • AI Market Dynamics (Imaging)
    • Competitive Landscape
    • Takeaways for Vendors
  • US Market by Clinical Area
    • Forecast by Clinical Area (2023-2032, USD Mill)
    • U.S. AI-Imaging Outlook by Clinical Area (2023 -> 2032)
    • Key Dynamics to Watch
    • Implications for Vendors
  • US Market by Imaging Modality
    • Forecast by Modality (2023-2032, USD Mill)
    • U.S. Modality Outlook: Who Grows, Who Overtakes
    • Key Takeaways
  • US Market by Revenue Stream
    • Forecast by Revenue Stream (2023-2032, USD Mill)
    • U.S. Revenue Stream Shift: From Capital Boxes to Recurring Bytes
    • What's Driving the Mix Change
    • Implications for Vendors
  • US Market by Clinical Application
    • Forecast by Clinical Application (2023-2032, USD Mill)
    • Outlook by Clinical Application
    • Highlights
    • Implications
  • US Market by End-Use Organization
    • Forecast by End-Use Organization (2023-2032, USD Mill)
    • Who Buys AI-and How That Mix Shifts Through 2032
    • What's Behind the Shift
    • Strategic Implications for Vendors
  • US Market by AI Technology
    • Forecast by AI Technology (2023-2032, USD Mill)
    • Outlook by Core Technology (2023-2032)
  • Markintel Growth Maturity Matrix - US & Canada
    • Competitive Dataset - United States
    • Competitive Context - U.S./North America
    • What to Watch Next
  • Markintel Solution Adoption & Growth Matrix - US & Canada
    • Scorecard - Solution Adoption & Growth Matrix (U.S. & Canada)
    • Strategic Implications for Stakeholders
  • Markintel Ecosystem Collaboration Matrix - US & Canada
    • Who to Partner with and How Deep?
    • What Succeess Looks Like in Each Quadrant
    • Stratregic Guidance
  • GTM at a Glance - United States
    • Channel & Pricing Matrix
    • GTM Readiness Radar - US
    • Customer Tier Potential - US
    • GTM Timeline (2025-2028) - US
    • Fast Strategic Cues (2025)
    • Regulatory x Funding Heatmap - US
    • Adjacency-Opportunity Radar - US
    • Whitespace Partner-Fit Matrix - US

SECTION 5 - CANADIAN MARKET

  • Market Summary: Canada
    • Key Market Dynamics
    • Strategic Takeaways
    • Top 3 Recommendations
  • Market Overview - Canada
    • Demographics & Epidemiology
    • Imaging Supply & Utilization
    • Health System & Practice Patterns
    • Regulatory & Reimbursement
    • AI-Imaging Market Dynamics
    • Competitive Snapshot
    • Key Implications
  • Canadian Market by Clinical Area
    • Forecast by Clinical Area (2023-2032, USD Mill)
    • Outlook by Clinical Area
    • Key Dynamics to Watch
    • Implications for Vendors
  • Canadian Market by Imaging Modality
    • Forecast by Imaging Modality (2023-2032, USD Mill)
    • Outlook by Modality
    • Key Dynamics to Watch (2025-27)
    • Implications for Vendors
  • Canadian Market by Revenue Stream
    • Forecast by Revenue Stream (2023-2032, USD Mill)
    • What's Driving Each Revenue Stream
    • Key Dynamics to Watch
    • Implications for Vendors
  • Canadian Market by Clinical Application
    • Forecast by Clinical Application (2023-2032, USD Mill)
    • Outlook & Drivers by Application
    • Key Market Dynamics to 2027
    • Implications for Vendors and Providers
  • Canadian Market by End-Use Organization
    • Forecast by End-Use Organization (2023-2032, USD Mill)
    • Outlook 2025-2032
    • Key Drivers by Segment
    • Implications for Vendors
    • Strategic Takeaways
  • Canadian Market by AI Technology
    • Forecast by AI Technology (2023-2032, USD Mill)
    • Highlights by Technology
    • Key Dynamics to Watch (2025 27)
    • Implications for Vendors & Providers
  • GTM at a Glance - Canada
    • GTM Readiness Radar - Canada
    • Tiered Customer Landscape
    • Channel & Pricing Matrix
    • GTM Timeline (Canada)
    • Fast Cues for 2025 Stakeholders